Vir Biotechnology
Vir Biotechnology is seeking an Associate Director, Principal Data Engineer to lead the development of scalable data, cloud, software, and AI-enabled research platforms that support scientific discovery, clinical data analysis, and program decision-making. The role focuses on building AI-powered research workflows, integrating scientific platforms, and architecting AWS cloud infrastructure while collaborating across research, clinical, data science, and IT teams.
Headquarters
San Francisco, California, United States
Company Size
501-1000 employees
Founded
2016
Vir Biotechnology is a clinical-stage immunology company that leverages the immune system to address critical unmet medical needs in infectious diseases and oncology. Its pipeline is built on two core technology platforms: a next-generation antibody and T-cell engager platform focused on infectious diseases, and the PRO-XTEN® protease-releasable masking technology applied to oncology and infectious disease. With foundational programs including chronic hepatitis delta, COVID-19, and Ebola, Vir works to engineer antibody-based medicines and deliver potentially transformative treatments to patients worldwide.
Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
3 weeks ago
Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Rating of "Moderate Buy" from Analysts
4 days ago
Vir Biotechnology Astellas Deal Puts VIR-5500 And Valuation In Focus
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Vir Biotechnology.
9% below the average for this role
Astellas, Vir Biotechnology Launch Up-to-$1.7B Prostate Cancer Collaboration
3 weeks ago